CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC)
Clinical trials for CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC) explained in plain language.
Never miss a new study
Get alerted when new CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC) trials appear
Sign up with your email to follow new studies for CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a shot replace the knife for skin cancer?
Disease control Recruiting nowThis study tests whether injecting the drug cemiplimab directly into early-stage skin cancer tumors can work as well as surgery to remove them. About 369 adults with a type of skin cancer called cutaneous squamous cell carcinoma will be randomly assigned to get either the injecti…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC)
Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 04:04 UTC
-
Experimental virus injection takes on Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase trial tests a new treatment called VET3-TGI, a virus designed to infect and kill cancer cells. It is given alone or with an immunotherapy drug (atezolizumab) to about 60 adults with advanced solid tumors that have not responded to standard treatments. The main go…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC)
Phase: PHASE1 • Sponsor: KaliVir Immunotherapeutics • Aim: Disease control
Last updated May 26, 2026 03:59 UTC
-
New hope for advanced skin cancers: first human trial launches
Disease control Recruiting nowThis early-stage trial tests a new drug called KUP-101A in 21 people with advanced skin cancers (like melanoma or Merkel cell carcinoma) that have not responded to standard treatments. The main goal is to find a safe dose and check for side effects. Researchers will also look at …
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC)
Phase: PHASE1 • Sponsor: Kupando GmbH • Aim: Disease control
Last updated May 26, 2026 03:55 UTC
-
New study tests if radiation after surgery prevents skin cancer return
Disease control Recruiting nowThis study tests whether giving radiation therapy after surgery helps prevent high-risk skin cancer from coming back, compared to just monitoring. About 266 adults with a type of skin cancer called cutaneous squamous cell carcinoma will be randomly assigned to receive radiation o…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC)
Phase: PHASE3 • Sponsor: Centre Leon Berard • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
Blood test may predict head and neck cancer return
Knowledge-focused Recruiting nowThis study is testing whether a blood test that looks for tumor DNA can find signs of cancer left behind after treatment for head and neck cancer. Researchers will follow 250 adults who have finished curative treatment to see if the test results match up with whether the cancer c…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC)
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated May 26, 2026 04:05 UTC
-
Blood test could predict who benefits from skin cancer drug
Knowledge-focused Recruiting nowThis study aims to find biological markers in the blood and tumor that can predict which patients with a common skin cancer will respond to the immunotherapy drug cemiplimab, and who might experience side effects. Researchers will use advanced cell analysis techniques to study im…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC)
Sponsor: Instituto de Investigación Biomédica de Salamanca • Aim: Knowledge-focused
Last updated May 26, 2026 04:05 UTC
-
Flu vaccine injected into skin cancer: could it rally immune cells?
Knowledge-focused Recruiting nowThis study is for people with a type of skin cancer called cutaneous squamous cell carcinoma who are waiting to have surgery to remove the tumor. Researchers want to see if injecting the seasonal flu vaccine directly into the tumor can attract more immune cells to fight the cance…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC)
Phase: EARLY_PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Knowledge-focused
Last updated May 26, 2026 03:52 UTC
-
Can a simple blood test predict skin cancer outcomes?
Knowledge-focused Recruiting nowThis study looks at blood samples from 20 people with melanoma or other skin cancers to see if certain markers in the blood can predict how well treatment works or how long patients live. Participants give blood during their regular care. The goal is to find better ways to monito…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC)
Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated May 22, 2026 13:53 UTC